TOP3B
Basic information
Region (hg38): 22:21957025-21982813
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOP3B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 15 | ||||
missense | 47 | 54 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 3 | 5 | |||
non coding | 1 | |||||
Total | 0 | 0 | 49 | 16 | 7 |
Variants in TOP3B
This is a list of pathogenic ClinVar variants found in the TOP3B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-21957128-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
22-21957143-T-A | not specified | Uncertain significance (Oct 07, 2024) | ||
22-21957163-G-C | not specified | Uncertain significance (Feb 23, 2023) | ||
22-21957193-C-T | not specified | Uncertain significance (May 24, 2024) | ||
22-21957199-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
22-21957209-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
22-21957214-C-T | not specified | Uncertain significance (Mar 17, 2023) | ||
22-21957227-C-T | not specified | Uncertain significance (Oct 28, 2023) | ||
22-21957230-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
22-21957233-G-A | not specified | Uncertain significance (Aug 01, 2024) | ||
22-21957233-G-C | not specified | Uncertain significance (Dec 06, 2023) | ||
22-21957235-T-C | not specified | Uncertain significance (Feb 13, 2024) | ||
22-21957251-A-C | not specified | Uncertain significance (Jul 14, 2024) | ||
22-21957302-C-T | not specified | Uncertain significance (Aug 08, 2023) | ||
22-21957317-G-A | Uncertain significance (Feb 01, 2024) | |||
22-21957326-C-T | not specified | Uncertain significance (Apr 16, 2024) | ||
22-21957328-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
22-21957386-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
22-21957409-C-T | not specified | Uncertain significance (Oct 09, 2024) | ||
22-21957413-C-A | not specified | Uncertain significance (Dec 21, 2023) | ||
22-21957413-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
22-21957428-C-T | Benign (Jul 01, 2023) | |||
22-21957443-C-A | not specified | Uncertain significance (May 03, 2023) | ||
22-21957483-C-T | Likely benign (Oct 01, 2022) | |||
22-21957510-G-A | Benign (Dec 18, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TOP3B | protein_coding | protein_coding | ENST00000398793 | 17 | 25817 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000214 | 1.00 | 125706 | 1 | 39 | 125746 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.23 | 381 | 524 | 0.726 | 0.0000336 | 5630 |
Missense in Polyphen | 101 | 160.15 | 0.63066 | 1649 | ||
Synonymous | 0.139 | 223 | 226 | 0.988 | 0.0000161 | 1659 |
Loss of Function | 3.88 | 14 | 40.7 | 0.344 | 0.00000204 | 482 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000333 | 0.000333 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000286 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000286 | 0.000272 |
South Asian | 0.000360 | 0.000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand than undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Possesses negatively supercoiled DNA relaxing activity. {ECO:0000250}.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.255
Intolerance Scores
- loftool
- rvis_EVS
- -0.48
- rvis_percentile_EVS
- 22.75
Haploinsufficiency Scores
- pHI
- 0.268
- hipred
- Y
- hipred_score
- 0.704
- ghis
- 0.576
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Top3b
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; immune system phenotype; respiratory system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; digestive/alimentary phenotype; renal/urinary system phenotype;
Gene ontology
- Biological process
- DNA topological change;chromosome segregation
- Cellular component
- condensed chromosome;nucleus
- Molecular function
- DNA binding;RNA binding;DNA topoisomerase activity;DNA topoisomerase type I activity;protein binding